News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Cataloguing brain cancer in children – Hudson Institute celebrates funding
An ambitious project to identify and characterise the rarest and deadliest forms of brain cancer in children has received a welcome funding boost.… Read more
-
Neural stem cells may hold key to tackling newborn brain injury
Neural Stem Cells have strong potential to be effective in reducing brain injury in newborn babies, in the most extensive review of research on the topic.… Read more
-
Early intervention treatment for cerebral palsy shows promise despite sex differences
A promising early intervention treatment for cerebral palsy in newborn babies has proven effective in both boys and girls – even though it works differently depending on the sex of the offspring.… Read more
-
H.pylori vaccine research targets stomach cancer
A bacterium present in half the world’s population, Helicobacter pylori is the target of new research aiming to develop a vaccine against stomach cancer. … Read more
-
Making more effective and efficient RNA therapeutics
RNA technology developed by Hudson Institute of Medical Research with the potential to limit inflammatory side-effects of RNA therapeutics such as mRNA vaccines, is the subject of a new licensing deal.… Read more
-
Brain injury at birth – a better start for newborns
Newborn babies who suffer asphyxia at birth could face significantly less risk of disability, thanks to a new treatment developed by Hudson Institute and Monash University scientists.… Read more
-
2021 NHMRC Ideas Grants success
Hudson Institute has again been recognised in the awarding of NHMRC Ideas Grants. These grants support innovative and creative research and build on Australia’s strong skills and international reputation in advanced health and medical research.… Read more
-
Flicking the inflammation off-switch
Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.… Read more -
Pelvic organ prolapse treatment attracts international award
Hudson Institute researcher, Dr Shayanti Mukherjee, has won the prestigious international Women in STEM2D Scholar Award for her ground-breaking bioengineering work in helping women with pelvic organ prolapse (POP). … Read more
-
Hudson CEO appointed to NHMRC Council
Hudson Institute has again been recognised as a leader in medical research with our CEO & Director appointed to the Council of the National Health and Medical Research Council (NHMRC).… Read more